Interesting CLL date from Medscape: Probably... - CLL Support

CLL Support

23,253 members39,948 posts

Interesting CLL date from Medscape

Petroc profile image
2 Replies

Probably ‘old hat’ for the likes of Neil, et al,(Jan 23) but some may find it of interest re improved responses to new therapies & drug / BTK combinations.

medscape.com/recap/981802

Written by
Petroc profile image
Petroc
To view profiles and participate in discussions please or .
2 Replies
DRM18 profile image
DRM18

The link brought me to a log-in page.

Any summary you can offer?

--Dave!

Petroc profile image
Petroc in reply toDRM18

Hi Dave, the gist of it is all good news. Basically survival outcomes are now approaching those in the general population in terms of life expectancy. What follows is the final section of the article for more refractory forms of CLL.

Another study focused on the triple combination of acalabrutinib, venetoclax, and obinutuzumab in treatment-naive patients with high-risk disease for whom the latter two therapies proved suboptimal. The triple combination delivered durable responses in this group.Next, Dr Burger turns to a long-term pooled analysis of patients aged 65 years or older who were treated with ibrutinib in the first-line setting. The study compared survival among these patients vs age-matched persons without CLL in the general population and found comparable survival in these two groups.In relapsed/refractory disease, Dr Burger discusses pirtobrutinib, an emerging Bruton tyrosine kinase inhibitor (BTKi), which demonstrated efficacy in heavily pretreated patients regardless of prior therapy, reason for discontinuation of previous therapy, or mutation status.He closes by examining results for the second-generation BTKi zanubrutinib showing superior progression-free survival compared with the first-generation agent ibrutinib in the phase 3 ALPINE study.

Not what you're looking for?

You may also like...

Exhaustion from CLL

Tired from CLL. DIAGNOSED 26 months ago. So far my problem has been only tiredness. No other...
Brigidoon profile image

My Take on 3 Interesting Papers on CLL from ASCO 2015

Friends, This week on CLL Society (http://cllsociety.org) in our 2015 conference coverage...
bkoffman profile image
CLL CURE Hero

Treatment for CLL from NEJM

A very interesting article from New England Journal of Medicine ( if you have trouble with link I...
jdolinger profile image

Second cancer from CLL???

Hi. My name is Dianne and have had CLL for about 5 years. Thanks God no treatment needed yet....
dcfrey profile image

Op date.....

Hi Everyone Well pre-op date for hubby is the 29th March at the Horton in Banbury and op date is...
Susiecarer profile image

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
Jm954 profile image
Jm954Administrator
AussieNeil profile image
AussieNeilAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.